Strategies for iron supplementation: Oral versus intravenous Iain C. Macdougall Kidney International Volume 55, Pages S61-S66 (March 1999) DOI: 10.1046/j.1523-1755.1999.055Suppl.69061.x Copyright © 1999 International Society of Nephrology Terms and Conditions
Figure 1 Hemoglobin response (mean ±SD) in three groups of erythropoietin-treated patients with different regimens of iron supplementation. Symbols are: (•) i.v. iron; (○) oral iron; (▪) no iron; *P < 0.05; **P < 0.005 vs. i.v. iron-treated group. Taken from Macdougall et al22; used with permission. Kidney International 1999 55, S61-S66DOI: (10.1046/j.1523-1755.1999.055Suppl.69061.x) Copyright © 1999 International Society of Nephrology Terms and Conditions
Figure 2 Mean hematocrit in two groups of patients receiving erythropoietin. Squares indicate the intravenous iron group; diamonds indicate the oral iron group. *P < 0.05. Taken from Fishbane et al20; used with permission. Kidney International 1999 55, S61-S66DOI: (10.1046/j.1523-1755.1999.055Suppl.69061.x) Copyright © 1999 International Society of Nephrology Terms and Conditions
Kidney International 1999 55, S61-S66DOI: (10. 1046/j. 1523-1755. 1999 Kidney International 1999 55, S61-S66DOI: (10.1046/j.1523-1755.1999.055Suppl.69061.x) Copyright © 1999 International Society of Nephrology Terms and Conditions
Kidney International 1999 55, S61-S66DOI: (10. 1046/j. 1523-1755. 1999 Kidney International 1999 55, S61-S66DOI: (10.1046/j.1523-1755.1999.055Suppl.69061.x) Copyright © 1999 International Society of Nephrology Terms and Conditions
Kidney International 1999 55, S61-S66DOI: (10. 1046/j. 1523-1755. 1999 Kidney International 1999 55, S61-S66DOI: (10.1046/j.1523-1755.1999.055Suppl.69061.x) Copyright © 1999 International Society of Nephrology Terms and Conditions